These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 33081794)

  • 21. Statewide Assessment of the Hepatitis C Virus Care Cascade for Incarcerated Persons in Vermont.
    Hale AJ; Mathur S; Dejace J; Lidofsky SD
    Public Health Rep; 2023; 138(2):265-272. PubMed ID: 35264027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased diagnosis and treatment of hepatitis C in prison by universal offer of testing and use of telemedicine.
    Morey S; Hamoodi A; Jones D; Young T; Thompson C; Dhuny J; Buchanan E; Miller C; Hewett M; Valappil M; Hunter E; McPherson S
    J Viral Hepat; 2019 Jan; 26(1):101-108. PubMed ID: 30315691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C treatment as prevention in the prison setting: Assessments of acceptability of treatment scale up efforts by prison correctional and health personnel.
    Lafferty L; Rance J; Dore GJ; Grebely J; Lloyd AR; Treloar C;
    Int J Drug Policy; 2021 Dec; 98():103379. PubMed ID: 34311138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modelling the impact of incarceration and prison-based hepatitis C virus (HCV) treatment on HCV transmission among people who inject drugs in Scotland.
    Stone J; Martin NK; Hickman M; Hutchinson SJ; Aspinall E; Taylor A; Munro A; Dunleavy K; Peters E; Bramley P; Hayes PC; Goldberg DJ; Vickerman P
    Addiction; 2017 Jul; 112(7):1302-1314. PubMed ID: 28257600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Previous incarceration impacts access to hepatitis C virus (HCV) treatment among HIV-HCV co-infected patients in Canada.
    Kronfli N; Nitulescu R; Cox J; Moodie EE; Wong A; Cooper C; Gill J; Walmsley S; Martel-Laferrière V; Hull MW; Klein MB;
    J Int AIDS Soc; 2018 Nov; 21(11):e25197. PubMed ID: 30460791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of direct-acting antiviral regimens and telemedicine on the treatment of inmates with hepatitis C virus infection in Israeli prisons.
    Richter V; Goldstein L; Cohen DL; Bermont A; Zelnik Yovel D; Madar M; Rabinovitch R; Shirin H; Broide E
    Sci Prog; 2022; 105(2):368504221105173. PubMed ID: 35722762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis virus (HCV) diagnosis and access to treatment in a UK cohort.
    Adland E; Jesuthasan G; Downs L; Wharton V; Wilde G; McNaughton AL; Collier J; Barnes E; Klenerman P; Andersson M; Jeffery K; Matthews PC
    BMC Infect Dis; 2018 Sep; 18(1):461. PubMed ID: 30217169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of telehealth to increase treatment access for prisoners with chronic hepatitis C.
    Halder A; Li VG; Sebastian M; Nazareth S; Tuma R; Cheng W; Doyle A
    Intern Med J; 2021 Aug; 51(8):1344-1347. PubMed ID: 34423535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An evaluation of the hepatitis C testing, care and treatment program in the country of Georgia's corrections system, December 2013 - April 2015.
    Harris AM; Chokoshvili O; Biddle J; Turashvili K; Japaridze M; Burjanadze I; Tsertsvadze T; Sharvadze L; Karchava M; Talakvadze A; Chakhnashvili K; Demurishvili T; Sabelashvili P; Foster M; Hagan L; Butsashvili M; Morgan J; Averhoff F
    BMC Public Health; 2019 May; 19(Suppl 3):466. PubMed ID: 32326938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of social capital in facilitating hepatitis C treatment scale-up within a treatment-as-prevention trial in the male prison setting.
    Lafferty L; Rance J; Dore GJ; Lloyd AR; Treloar C
    Addiction; 2021 May; 116(5):1162-1171. PubMed ID: 33006784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decentralisation, integration, and task-shifting in hepatitis C virus infection testing and treatment: a global systematic review and meta-analysis.
    Oru E; Trickey A; Shirali R; Kanters S; Easterbrook P
    Lancet Glob Health; 2021 Apr; 9(4):e431-e445. PubMed ID: 33639097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C Virus Reinfection Following Direct-Acting Antiviral Treatment in the Prison Setting: The SToP-C Study.
    Carson JM; Dore GJ; Lloyd AR; Grebely J; Byrne M; Cunningham E; Amin J; Vickerman P; Martin NK; Treloar C; Martinello M; Matthews GV; Hajarizadeh B;
    Clin Infect Dis; 2022 Nov; 75(10):1809-1819. PubMed ID: 35362522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recently acquired hepatitis C virus infection among people living with human immunodeficiency virus at a university hospital in Taiwan.
    Huang MH; Sun HY; Ho SY; Chang SY; Hsieh SM; Sheng WH; Chuang YC; Huang YS; Su LH; Liu WC; Su YC; Hung CC
    World J Gastroenterol; 2021 Oct; 27(37):6277-6289. PubMed ID: 34712032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection, stratification and treatment of hepatitis C-positive prisoners in the United Kingdom prison estate: Development of a pathway of care to facilitate the elimination of hepatitis C in a London prison.
    Connoley D; Francis-Graham S; Storer M; Ekeke N; Smith C; Macdonald D; Rosenberg W
    J Viral Hepat; 2020 Oct; 27(10):987-995. PubMed ID: 32449969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre- and post-universal access to direct-acting antiviral treatment in Australia: The LiveRLife study.
    Bajis S; Grebely J; Hajarizadeh B; Applegate T; Marshall AD; Ellen Harrod M; Byrne J; Bath N; Read P; Edwards M; Gorton C; Hayllar J; Cock V; Peterson S; Thomson C; Weltman M; Jefferies M; Wood W; Haber P; Ezard N; Martinello M; Maher L; Dore GJ;
    J Viral Hepat; 2020 Mar; 27(3):281-293. PubMed ID: 31698545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The continuum of hepatitis C care for criminal justice involved adults in the DAA era: a retrospective cohort study demonstrating limited treatment uptake and inconsistent linkage to community-based care.
    Hochstatter KR; Stockman LJ; Holzmacher R; Greer J; Seal DW; Taylor QA; Gill EK; Westergaard RP
    Health Justice; 2017 Oct; 5(1):10. PubMed ID: 29086078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of HCV infection in the penitentiary setting in the direct-acting antivirals era: practical recommendations from an expert panel.
    Ranieri R; Starnini G; Carbonara S; Pontali E; Leo G; Romano A; Panese S; Monarca R; Prestileo T; Barbarini G; Babudieri S;
    Infection; 2017 Apr; 45(2):131-138. PubMed ID: 28025726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Real-life experience of hepatitis C treatment in a Spanish prison.
    Tejera-Pérez RJ; Iglesias-Gómez A; Oliva-Oliva A; Rodríguez-Alonso B; Alonso-Sardón M; Sánchez Ledesma M; Carbonell-Muñoz C; Pendones Ulerio J; Muñoz-Bellido JL; Belhassen-García M
    Rev Esp Quimioter; 2022 Jun; 35(3):273-278. PubMed ID: 35441836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Understanding facilitators and barriers of direct-acting antiviral therapy for hepatitis C virus infection in prison.
    Lafferty L; Rance J; Grebely J; Lloyd AR; Dore GJ; Treloar C;
    J Viral Hepat; 2018 Dec; 25(12):1526-1532. PubMed ID: 30141261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Performance of a rapid diagnostic test for screening of hepatitis C in a real-life prison setting.
    Sharafi H; Poustchi H; Azimian F; Tamadoni B; Ramezani R; Gouya MM; Sheikh M; Hashemi F; Tashakorian M; Alasvand R; Alavian SM; Merat S
    J Clin Virol; 2019 Apr; 113():20-23. PubMed ID: 30825832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.